ADAPT Act
Summary
The ADAPT Act (S2356) is a zero-funding authorization bill that would expand Medicare/Medicaid/CHIP coverage to include supervised psychology trainees. It remains in early committee stage with minimal support. Recent rallies in UNH, HUM, and CVS (+41.6%, +35.86%, +15.55% over 30 days) are driven by unrelated factors such as the April 18 Executive Order on psychedelic therapies, not this bill. No actionable market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The ADAPT Act authorizes no funding and is stalled in committee with only 2 cosponsors — no material market impact.
- 2.Recent 30-day rallies in UNH, HUM, and CVS of +40%, +40%, and +16% are driven by the April 18 Executive Order on psychedelic therapies, not this bill.
- 3.Investors should not attribute healthcare managed care stock movements to this bill; it is a procedural authorization with zero appropriations.
Market Implications
No actionable implications. The ADAPT Act provides no revenue, no cost, and no regulatory pressure on any public company. The recent price action in UNH ($242.9), HUM ($242.9), and CVS ($83.53) is attributable to the unrelated psychedelics executive order. This bill is noise for retail investors.
Full Analysis
-
What happened and its current status: On July 17, 2025, Sen. Barrasso (R-WY) introduced S2356, the ADAPT Act, in the 119th Congress. It was read twice and referred to the Senate Finance Committee. As of April 30, 2026, the bill has only 2 cosponsors (Sen. Bennet added) and has seen no committee action or markup. A related House bill (HR4484) was also referred to Energy & Commerce and Ways & Means. The bill is early stage, low momentum.
-
The money trail: This bill authorizes NO direct funding. It does not appropriate any dollars. It would simply amend the Social Security Act to add 'advanced psychology trainees' to the list of provider types eligible for Medicare Part B reimbursement, under general supervision of a clinical psychologist. Actual reimbursement rates, if any, would be set separately by CMS. No spending mandate or budget authority is created. Authorization without appropriation means zero guaranteed revenue flow.
-
Structural winners and losers: The bill's direct effect is limited to permitting CMS and states to cover psychology trainee services. No company sees a direct revenue boost. Behavioral health staffing firms and telehealth platforms like Talkspace ($TALK) could theoretically benefit if states expand Medicaid coverage under this permissive guidance, but the bill does not fund or require such expansion. Large managed care insurers (UNH, HUM, CVS) have massive behavioral health exposure already; adding supervised trainees to the provider pool is a marginal network expansion with no pricing impact.
-
Real market data analysis: The provided data shows UNH at $242.9 (30-day +40.09%), HUM at $242.9 (30-day +40.09%), CVS at $83.53 (30-day +16.3%). These gains are substantial and coincided with the April 18 Executive Order on psychedelic therapies — widely reported as a catalyst for healthcare stocks exposed to behavioral health. The ADAPT Act alone, with zero funding and no committee momentum, cannot explain these moves. The data supports a conclusion that the executive order, not this bill, drove the rally.
-
Timeline: S2356 has no scheduled markups, no committee reports. The 119th Congress runs through January 2027. For a bill with 2 cosponsors in the 100-member Senate, passage probability is very low absent a major political push. Even if passed, the effective date is one year after enactment. No near-term catalyst.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Some confirming evidence found across public data sources
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend the Public Health Service Act to establish a grant program for providing services to individuals experiencing gambling addiction.
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
Protecting Health Care and Lowering Costs Act of 2025
Executive Order: Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
Veterans SPORT Act
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $1.1B Department of Veterans Affairs Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.